Pricing Log in Create free account

MBX Biosciences, Inc. (MBX) vs Pharvaris N.V. (PHVS)

MBX Biosciences, Inc. and Pharvaris N.V. are both Biotechnology companies. MBX Biosciences, Inc. and Pharvaris N.V. are of similar size ($2.3B and $2.3B). Across the 9 metrics below, MBX Biosciences, Inc. leads on 8 and Pharvaris N.V. on 1.

Valuation

Metric MBX PHVS Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 5.66 6.38 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (4.96%) (9.30%) (34.89%)
Free cash flow yield (3.68%) (7.98%) (24.52%)

Profitability

Metric MBX PHVS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (33.17%) (71.50%) (50.12%)
Return on assets (31.25%) (64.43%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MBX PHVS Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 59.11% (25.37%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MBX PHVS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 18.08 11.94 4.89
Net debt to EBITDA 3.82 1.72 1.01

Dividend

Metric MBX PHVS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MBX PHVS Biotechnology median
Market cap 2.33b 2.28b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack